Tcg Crossover Management, LLC Silence Therapeutics PLC Transaction History
Tcg Crossover Management, LLC
- $415 Million
- Q1 2025
A detailed history of Tcg Crossover Management, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 3,033,560 shares of SLN stock, worth $15.3 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
3,033,560
Previous 3,033,560
-0.0%
Holding current value
$15.3 Million
Previous $20.9 Million
59.01%
% of portfolio
2.06%
Previous 3.41%
Shares
3 transactions
Others Institutions Holding SLN
# of Institutions
61Shares Held
22.7MCall Options Held
1.3KPut Options Held
2.6K-
Siren, L.L.C. New York, NY2.79MShares$14.1 Million0.45% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$11.2 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$10.1 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$9.32 Million0.44% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.15MShares$5.79 Million0.2% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $181M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...